Beatrice Turcq

Beatrice Turcq

UNVERIFIED PROFILE

Are you Beatrice Turcq?   Register this Author

Register author
Beatrice Turcq

Beatrice Turcq

Publications by authors named "Beatrice Turcq"

Are you Beatrice Turcq?   Register this Author

19Publications

178Reads

32Profile Views

Novel analytical methods to interpret large sequencing data from small sample sizes.

Hum Genomics 2019 08 30;13(1):41. Epub 2019 Aug 30.

Laboratory of Mammary and Leukaemic Oncogenesis, Inserm U1218 ACTION, Bergonié Cancer Institute, University of Bordeaux, 146 rue Léo Saignat, bâtiment TP 4ème étage, case 50, 33076, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40246-019-0235-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717342PMC
August 2019

A new mechanism of resistance to ABL1 tyrosine kinase inhibitors in a BCR-ABL1-positive cell line.

Leuk Res 2017 10 31;61:44-52. Epub 2017 Aug 31.

University of Bordeaux, Bordeaux, France; Flow Cytometry Laboratory, CHU Haut-Lévêque, Pessac, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2017.08.014DOI Listing
October 2017

Loss of mutL homolog-1 (MLH1) expression promotes acquisition of oncogenic and inhibitor-resistant point mutations in tyrosine kinases.

Cell Mol Life Sci 2016 12 19;73(24):4739-4748. Epub 2016 Jul 19.

Ludwig Institute for Cancer Research, Brussels Branch, Avenue Hippocrate 74, 1200, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00018-016-2310-2DOI Listing
December 2016

A single nucleotide polymorphism in cBIM is associated with a slower achievement of major molecular response in chronic myeloid leukaemia treated with imatinib.

PLoS One 2013 5;8(11):e78582. Epub 2013 Nov 5.

Université Bordeaux Segalen and INSERM U1035 Bordeaux, Bordeaux, France ; Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0078582PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818406PMC
August 2014

ABT-737 increases tyrosine kinase inhibitor-induced apoptosis in chronic myeloid leukemia cells through XIAP downregulation and sensitizes CD34(+) CD38(-) population to imatinib.

Exp Hematol 2012 May 10;40(5):367-78.e2. Epub 2012 Jan 10.

Laboratoire d'Hématopoïèse Leucémique et Cibles Thérapeutiques, INSERM 1035, Université Bordeaux Segalen, Bordeaux Cedex, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0301472X120000
Publisher Site
http://dx.doi.org/10.1016/j.exphem.2012.01.004DOI Listing
May 2012

Evidence that resistance to nilotinib may be due to BCR-ABL, Pgp, or Src kinase overexpression.

Cancer Res 2008 Dec;68(23):9809-16

Hématopoïèse Leucémique et Cible Thérapeutique, INSERM U876, Université Victor Ségalen, Laboratoire d'hématologie CHU de Bordeaux, Bordeaux cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-1008DOI Listing
December 2008

Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia.

Blood 2008 Sep 4;112(5):2024-7. Epub 2008 Jun 4.

Laboratoire Hématopoïèse Leucémique et Cible Thérapeutique, Université Victor Ségalen Bordeaux 2, Inserm U876, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-03-147744DOI Listing
September 2008

A rapid and efficient method using chromoslots to assign any newly cloned DNA sequence to its cognate chromosome in the filamentous fungus Podospora anserina.

FEMS Microbiol Lett 2002 Oct;216(1):55-60

Laboratoire de Biologie et Génomique de Podospora, Institut de Biochimie et Génétique Cellulaires, UMR CNRS 5095, Université de Bordeaux 2, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1574-6968.2002.tb11414.xDOI Listing
October 2002